CME / CE - Physicians' Education Resource

Customize

Quick Links

Why CME?

Europe

Specialties

2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2018
Physicians’ Education Resource ®, LLC.
All rights reserved.

All Activities

Community Practice Connections™: Personalized Assessment in Advanced RCC Decision Making: Leveraging the Evidence and Patient Characteristics to Inform Decisions Along the Disease Continuum

Expires on April 30, 2019

CME: 1.5

The Provider and Caregiver Connection: Multiple Sclerosis: A Treatment Paradigm Shift When “Time Is Brain”

Expires on April 30, 2019

CNE: 2.0

CME: 2.0

Advances in™ Diagnostic Guidelines for Effective Clinical Decision - Making in the Management of Hematologic Malignancies

Expires on April 30, 2019

CME: 1.5

Community Practice Connections™: Emerging Paradigm Shifts in Renal Cell Carcinoma: A Critical Assessment of Adjuvant Treatment Data

Faculty: Robert A. Figlin, MD, FACP; Lauren C. Harshman, MD; Bradley C. Leibovich, MD, FACS; Alain Ravaud, MD, PhD; Brian I. Rini, MD, FACP

Expires on April 30, 2019

CME: 1.5

Oncology Consultations™: The Advancing Role of CAR T-Cell Therapies in Hematologic Malignancies

Faculty: Anas Younes, MD; Reiner J. Brentjens, MD, PhD

Expires on April 30, 2019

CME: 1.5

Community Practice Connections™: 14th Annual International Symposium on Melanoma and Other Cutaneous Malignancies®

Faculty: Omid Hamid, MD; Jeffrey S. Weber, MD, PhD; Jason J. Luke, MD, FACP

Expires on April 30, 2019

CNE: 2.0

CME: 2.0

Live Meetings

Live Webcast: Virtual Current Trends™: European Perspectives on the Advancing Role of Car T-Cell Therapy in Hematologic Malignancies

May 24, 2018
Live Webcast

CME: 3.0

ASCO: PARP Inhibition in Breast Cancer: Practical Methods to Interpret and Apply the Evidence for Your Patients

June 1, 2018
Chicago, IL

CNE: 2.0

CME: 2.0

ASCO: Medical Crossfire®: The Advent of CAR T-Cell Therapy for Lymphoid Malignancies and Beyond

June 1, 2018
Chicago, IL

CNE: 2.0

CME: 2.0

ASCO: Immunotherapeutic Strategies with the Potential to Transform Treatment for Genitourinary Cancers

June 1, 2018
Chicago, IL

CME: 2.0

ASCO: New Directions in Advanced Cutaneous Squamous Cell Carcinoma: Emerging Evidence of Immunotherapy

June 2, 2018
Chicago, IL

CNE: 2.0

CME: 2.0

ASCO: Matching Treatment to Patient in an Ever-Changing Era for the Management of Advanced Renal Cell Carcinoma: An Expert Tumor Board Discussion

June 2, 2018
Chicago, IL

CME: 2.0

ASCO: Medical Crossfire®: Evolving Applications for PARP Inhibitors in Ovarian Cancer: Building on a Solid Foundation

June 3, 2018
Chicago, IL

CNE: 2.0

CME: 2.0

ASCO: Transforming Treatment Paradigms in Renal Cell Carcinoma: Understanding the Role of Risk Stratification and Emerging Data in the Adjuvant Setting

June 3, 2018
Chicago, IL

CME: 1.5

ASCO: Navigating New Sequencing Challenges for the Treatment of Hepatocellular Carcinoma

June 3, 2018
Chicago, IL

CME: 2.0

2nd Annual International Congress on Oncology Pathology™: Towards Harmonization of Pathology and Oncology Standards

June 23, 2018
New York, NY

The American Diabetes Association’s 78th Scientific Sessions

June 25, 2018
Orlando, Florida

CME: 2.0

17th Annual International Congress on the Future of Breast Cancer® West

July 13-14, 2018
San Diego, CA

2nd Annual Live Medical Crossfire®: Hematologic Malignancies

July 14, 2018
New York, NY

CNE: 8.0

CME: 8.0

19th Annual International Lung Cancer Congress®

July 26-28, 2018
Huntington Beach, CA

17th Annual International Congress on the Future of Breast Cancer® East

July 27-28, 2018
New York, NY

2nd Annual School of Nursing Oncology™

August 3-4, 2018
Chicago, IL

3rd Annual European Congress on Immunotherapies in Cancer™

21-22 September 2018
Barcelona, Spain

3rd Annual European Congress on Hematology™: Focus on Lymphoid Malignancies

12-13 October 2018
Paris, France

16th Annual School of Breast Oncology®

November 1-3, 2018
Atlanta, GA

36th Annual CFS®

November 7-9, 2018
New York, NY

13th Annual New York Lung Cancers Symposium

November 10, 2018
New York, NY

2nd Annual Paris Breast Cancer Conference™

November 16-17, 2018
Paris, France

3rd Annual International Congress on Immunotherapies in Cancer™: Focus on Practice-Changing Application

December 15, 2018
New York, NY

16th Annual Winter Lung Cancer Conference™

January 25-27, 2019
Miami, FL

15th Annual International Symposium on Melanoma and Other Cutaneous Malignancies®

February 9, 2019
New York, NY

23rd Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas and Myeloma

February 28- March 3, 2019
Miami, FL

36th Annual Miami Breast Cancer Conference®

March 7-10, 2019
Miami, FL

4th Annual School of Gastrointestinal Oncology™ (SOGO®)

April 27, 2019
New York, NY

SUN	MON	TUES	WED	THURS	FRI	SAT
		1 Venous Thromboembolism Prophylaxis in Hospitalized Adult Patients: A Multidisciplinary Approach May 1, 2018 - May 31, 2019	2	3	4 2nd Annual European Symposium on Lung Cancers™ May 4, 2018 - May 5, 2018 Barcelona, Spain	5
6	7	8	9	10 Live Webcast: Virtual Current Trends™: Global Perspectives on Emerging Data in Hepatocellular Carcinoma May 10, 2018 Live Webcast CME 2.0	11	12
13	14	15	16	17 ONS: PER Forum™: Nursing Opportunities to Improve Outcomes With the Advent of PARP Inhibitors in the Care of Women’s Cancers May 17, 2018 Washington, DC CME 1.5 ONS: Working Group for Changing Standards in EGFR-Mutated Lung Cancers: Real-World Applications of the Evidence for Nurses May 17, 2018 Washington, DC CME 1.5	18	19 Advancing the Treatment of Bladder Cancers Using Evidence-Based Immuno-Oncology Strategies May 19, 2018 San Francisco, CA CME 2.0
20	21	22	23	24 Live Webcast: Virtual Current Trends™: European Perspectives on the Advancing Role of Car T-Cell Therapy in Hematologic Malignancies May 24, 2018 Live Webcast CME 3.0	25 34th Annual Miami Breast Cancer Conference® Clinical Case Vignette Series™ Expires on May 25, 2018 CME 2.0	26
27	28	29	30 Medical Crossfire®: Clinical Updates on PARP Inhibition and its Evolving Use in the Treatment of Cancers Expires on May 30, 2018 CME 1.5 Community Practice Connections™: CDK4/6 Inhibitors With the Experts: The Role of Emerging Agents for the Management of Metastatic Breast Cancer Expires on May 30, 2018 CME 2.0 Community Practice Connections™: Optimizing Outcomes in HER2-Positive Breast Cancer: Emerging Evidence and Practical Strategies in Early-Stage Treatment Settings Expires on May 30, 2018 CME 2.0 Community Practice Connections: New York GU™: 10th Annual Interdisciplinary Prostate Cancer Congress® and other Genitourinary Malignancies Expires on May 30, 2018 CME 1.5 Community Practice Connections™: Advancing RCC: A Focused Assessment of Recent Paradigm Shifts and Next Steps to Move the Field Forward Expires on May 30, 2018 CME 1.5	31 Oncology Briefings™: Updates in Novel Therapeutic Options for Lung Neuroendocrine Tumors Expires on May 31, 2018 CME 1.0 Oncology Briefings™: Updates in Pediatric Hepatic Veno-Occlusive Disease: Integrating Novel Therapeutic Strategies to Overcome Post-Transplant Obstacles Expires on May 31, 2018 CME 1.0 Oncology Briefings™: Emerging Treatment Options for Patients With High-Risk AML Expires on May 31, 2018 CME 1.0 Medical Crossfire®: Expert Perspectives on the Emerging Role of CDK4/6 Inhibitors for the Management of Metastatic Breast Cancer Expires on May 31, 2018 CME 1.0

Live Webcast Today: Virtual Current Trends™: European Perspectives on the Advancing Role of Car T-Cell Therapy in Hematologic Malignancies